These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21934556)

  • 21. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
    Townsend ML; Jackson GL; Smith R; Wilson KH
    Clin Ther; 2007 Apr; 29(4):711-6. PubMed ID: 17617294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which adherence measure - self-report, clinician recorded or pharmacy refill - is best able to predict detectable viral load in a public ART programme without routine plasma viral load monitoring?
    Mekuria LA; Prins JM; Yalew AW; Sprangers MA; Nieuwkerk PT
    Trop Med Int Health; 2016 Jul; 21(7):856-69. PubMed ID: 27118068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Utility of Pharmacy-Based Adherence Measurement in Predicting Virologic Outcomes in an Adult HIV-Infected Cohort in Jos, North Central Nigeria.
    Abah IO; Ojeh VB; Musa J; Ugoagwu P; Agaba PA; Agbaji O; Okonkwo P
    J Int Assoc Provid AIDS Care; 2016; 15(1):77-83. PubMed ID: 24963086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy: an observational cohort study.
    Court R; Leisegang R; Stewart A; Sunpath H; Murphy R; Winternheimer P; Ally M; Maartens G
    BMC Infect Dis; 2014 Dec; 14():664. PubMed ID: 25472544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort study.
    Hayashi K; Wood E; Kerr T; Dong H; Nguyen P; Puskas CM; Guillemi S; Montaner JS; Milloy MJ
    BMC Infect Dis; 2016 Aug; 16(1):455. PubMed ID: 27568002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of pharmacy refill data as a measure of antiretroviral adherence.
    Grossberg R; Gross R
    Curr HIV/AIDS Rep; 2007 Dec; 4(4):187-91. PubMed ID: 18366950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring of Delay to Pharmacy Refill in Assessing Adherence to Antiretroviral Therapy.
    Cruz CCP; Mistro S; Mendes CMC; Schooley RT; Badaró RJDS
    J Pharm Pract; 2020 Apr; 33(2):158-163. PubMed ID: 30122111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda.
    Bagenda A; Barlow-Mosha L; Bagenda D; Sakwa R; Fowler MG; Musoke PM
    Ann Trop Paediatr; 2011; 31(3):235-45. PubMed ID: 21781419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Analysis of two Methods of Measuring Antiretroviral Therapy Adherence in HIV-Infected Omani Patients.
    Gaifer Z; Boulassel MR
    J Int Assoc Provid AIDS Care; 2019; 18():2325958219867316. PubMed ID: 31389287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacy refill data can be used to predict virologic failure for patients on antiretroviral therapy in Brazil.
    Martin D; Luz PM; Lake JE; Clark JL; Campos DP; Veloso VG; Moreira RI; Cardoso SW; Klausner JD; Grinsztejn B
    J Int AIDS Soc; 2017 Jun; 20(1):21405. PubMed ID: 28605172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiretroviral Refill Adherence Correlates with, But Poorly Predicts Retention in HIV Care.
    Bonacci RA; Frasca K; Swift L; Sha D; Bilker WB; Bamford L; Yehia BR; Gross R
    AIDS Behav; 2016 May; 20(5):1060-7. PubMed ID: 26400078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Pharmacy Refill Measures in Assessing Adherence and Predicting HIV Disease Markers in Youth with Perinatally-Acquired HIV (PHIV).
    Yildirim C; Garvie PA; Chernoff M; Wilkins ML; Patton ED; Williams PL; Nichols SL;
    AIDS Behav; 2019 Aug; 23(8):2109-2120. PubMed ID: 30929147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral medication compliance in patients with AIDS.
    Frick PA; Gal P; Lane TW; Sewell PC
    AIDS Patient Care STDS; 1998 Jun; 12(6):463-70. PubMed ID: 11361994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the predictive performance of adherence measures for virologic failure detection in people living with HIV: a systematic review and pairwise meta-analysis.
    Almeida-Brasil CC; Moodie EEM; Cardoso TS; Nascimento ED; Ceccato MDGB
    AIDS Care; 2019 Jun; 31(6):647-659. PubMed ID: 30516060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of HIV-specialized pharmacies on adherence to medications for comorbid conditions.
    DuChane J; Clark B; Hou J; Fitzner K; Pietrandoni G; Duncan I
    J Am Pharm Assoc (2003); 2014; 54(5):493-501. PubMed ID: 25216879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.
    Fairley CK; Permana A; Read TR
    HIV Med; 2005 Sep; 6(5):366-9. PubMed ID: 16156886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria: A Randomized Controlled Trial of a Peer Support Intervention.
    Coker M; Etiebet MA; Chang H; Awwal G; Jumare J; Musa BM; Babashani M; Habib AG; Dakum P; Abimiku AG; Charurat ME; Blattner WA; Eng M; Ndembi N
    Curr HIV Res; 2015; 13(4):279-85. PubMed ID: 25845393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moving Antiretroviral Adherence Assessments to the Modern Era: Correlations Among Three Novel Measures of Adherence.
    Saberi P; Chakravarty D; Ming K; Legnitto D; Gandhi M; Johnson MO; Neilands TB
    AIDS Behav; 2020 Jan; 24(1):284-290. PubMed ID: 31758349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.
    Flandre P; Peytavin G; Meiffredy V; Saidi Y; Descamps D; Delagnes M; Brun-Vézinet F; Raffi F;
    Antivir Ther; 2002 Jun; 7(2):113-21. PubMed ID: 12212923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacy-refill measure of adherence to efavirenz can predict maintenance of HIV viral suppression.
    Saberi P; Caswell N; Amodio-Groton M; Alpert P
    AIDS Care; 2008 Jul; 20(6):741-5. PubMed ID: 18576177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.